Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Survival comparison of HER2 br...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Survival comparison of HER2 breast cancer patients according to HR status: analysis of a single Portuguese centre

Survival comparison of HER2 breast cancer patients according to HR status: analysis of a single Portuguese centre

Bibliographic Details
Main Authors: G. Nogueira-Costa, J. Gramaça, I. Fernandes, C. Trabulo, J. Gonçalves, I. Pina
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Breast
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977621002010
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S0960977621002010

Similar Items

  • Assessment of nutritional status of oncology patients at hospital admission: A Portuguese real-world study
    by: Carolina Trabulo, et al.
    Published: (2022-09-01)
  • Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2– metastatic breast cancer
    by: Forsythe A, et al.
    Published: (2018-05-01)
  • PIK3CA mutation status, progression and survival in advanced HR + /HER2- breast cancer: a meta-analysis of published clinical trials
    by: Mirko Fillbrunn, et al.
    Published: (2022-09-01)
  • Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2− metastatic breast cancer?
    by: Forsythe A, et al.
    Published: (2018-05-01)
  • Development and Validation of a Prognostic Nomogram for HR+ HER- Breast Cancer
    by: Zhou JY, et al.
    Published: (2024-05-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs